SLC Webinar: Animal Models of Human Disease for Nonclinical Safety—Why, What and When, June 21, 11:00 AM ET

The Scientific Liaison Coalition Use of Animal Models of Disease for Toxicity Prediction Webinar Series concludes June 21 at 11 am ET with a regulatory perspective presentated by Sherry Morgan, AbbVie, Inc.

This webinar series debuted May 17 with the first installment featuring Diann Blanset, Boehringer Ingelheim and continued on May 31 with the second installment featuring Sruthi King, US Food and Drug Administration. Recordings are available.

Animal Models of Human Disease for Nonclinical Safety—Why, What and When…

Tuesday, June 21, 11:00 AM–12:30 PM ET

Online Registration>>

Ellen Silbergeld, PhD

Presented by Sherry J. Morgan, DVM, PhD, ACVP, ABT, ABVT joined Abbott/AbbVie, Inc. in 1990. She currently serves a dual role as a pathologist and a Director of Scientific Projects, providing toxicology and pathology guidance for Discovery and Development projects. Dr. Morgan also provides interpretative nonclinical risk assessment summaries of numerous potential in-licensing compounds, helping to guide the selection process of novel compounds. She is board certified by the American College of Veterinary Pathologists, the American Board of Veterinary Toxicologists, and the American Board of Toxicology. Her publication list includes approximately 30 journal articles, 20 book chapters, and 30 abstracts/posters. Topics on the use of animal models span therapeutic indications including oncology, joint diseases, neurodegeneration, cardiovascular disease, and endocrine and metabolic diseases. She also has contributed to the validation of non-invasive imaging technologies using traditional pathology endpoints. In this presentation, the rationale for the use of animal models of disease will be discussed as it pertains to different adverse drug reactions for which there is relatively low predictability with conventional animal models. Some of the possible reasons for lack of concordance between different organ systems will be covered as well. The presentation will conclude with general recommendations when considering using an animal model of animal disease as well as some examples of studies involving animal models of disease.

This webinar is open to members of the Teratology Society through our membership in the SLC. You must register to attend using the link above.

Recordings of previous SLC webinars are available in the Educational Webinars File Library on BDR Connection.

 

Recent Stories
Announcing the New Teratology Society Innovator Award

FDA Launches Predictive Toxicology Roadmap

PODCAST: Secrets of the Human Brain Revealed: Development, Disease & the Zika Virus